References
- American Psychiatric Association. Diagnostic ancl Statistical Manual of Mental Disoirlers, Third Edition. American Psychiatric Association, Washington, DC, USA (1980).
- Kovacs M, Akiskal HS, Gatsonis C, Parrone PL. Childhood-onset dysthymic disorder. Clinical features and prospective naturalistic outcome. krh. Gen. Psychiatry 51, 365–374 (1994).
- •Demonstrated a manic outcome in some early-onset dysthymics.
- Klein DF, Schwartz JE, Rose S, Leader JB. Five-year course and outcome of dysthymic disorder: A prospective, naturalistic follow-up study. Am Psychiatry157,931–939 (2000).
- Keller MB, Shapiro RVV. Double depression: superimposition of acute depressive episodes as chronic depressive disorders. Am. j Psychiatry 139,438–442 (1982).
- American Psychiatric Association. Diagnostic and Statistical Manual ofMental disarlers, Fourth Edition. American Psychiatric Association, Washington, DC, USA (1994).
- Weissman M, Leaf PJ, Bruce ML et al The epidemiology of dysthymia in five communities: rates, risks, comorbidity and treatment. Am. j Psychiany145,815–819 (1988).
- Kessler RC, McGonagle IKA, Zhoa S eta]. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorder in the United States: results from the National Comorbidity Survey. Awl?. Gen Psychiatry 51,8–19 (1994).
- •Most recent epidemiolology study of dysthymic disorder.
- Hamilton M. A rating scale for depression. .1. Neural Neumsurg. PTchiatry23, 56–62 (1960).
- Shores MM, Glubin T, Cowley DS etal The relationship between anxiety and depression: a clinical comparison of generalized anxiety disorder, dysthymic disorder, panic disorder and major depressive disorder. Compr. Psychiatry 33, 237–244 (1992).
- Clark DA, Beck AT, Beck JS. Symptom differences in major depression, dysthymia, panic disorder and generalized anxiety disorder. A117. I Fiychiatry151,205–209 (1994).
- Friedman RA, Markowitz JC, Parides M etal Acute response of social functioning in dysthymic patients with desipramine. Affect Disoirler34, 85–88 (1995).
- Hirschfeld RMA, Montgomery SA, Keller MB etal Social functioning in depression: a review. j Gun. Psychiany61,268–275 (2000).
- Yang T, Dunner DL. Differential subtyping of depression. Depression ancl Anxiety13, 11–17 (2001).
- Klein DM, Riso LP, Donaldson SK et al Family study of early onset dysthymia. Arch. Gen. Psychiatry 52,487–496 (1995).
- ••Only family study of dysthmia thus farreported in the literature.
- Keller MB, Klein DN, Hirschfeld RMA et al Results of the DSM-IV mood disorders field trial. Am j PFchiatry152, 843–849 (1995).
- •Demonstrated symptom differences in dysthymic as compared with patients with chronic major depression.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Mind edition, revised. American Psychiatric Association, Washington DC, USA (1987).
- Han L, Schmaling KB, Dunner DL. Descriptive validity and stability of diagnostic criteria for dysthymic disorder. Comp: PTchiatry36, 338–343 (1995).
- ••Demonstrated that criteria for majordepressive disorder could be applied to dysthymia.
- Dunner DL. Duration of euthymia in dysthymic patients. Am. j PFchiatry156, 1992–1993 (1999).
- ••First study to provide data regarding theduration of euthymic periods in dysthymic patients.
- Frank E, Prien RF, Jarrett RB etal conceptualization and rationale of consensus definitions of terms in major depression and depressive disorder — remission, recovery, relapse and recurrence. Arch. Gen. Psychiatry 48,851–855 (1991).
- Beck AT Beck Depression Inventory (3DI) Center for Cognitive Therapy, Philadelphia, PA, USA (1978).
- Thase ME, Fava M, Halbreich U etal A placebo-controlled, randomized clinical trial comparing sertrline and imipramine for thetreatment of dysthymia. Awl?. Gen. Psychiatry53, 777–784 (1997).
- ••Largest treatnent study of dysthymia sofar reported.
- Gwirtsman HE, Blehar MC, McCollough JP Jr etal Standardized assessment of dysthymia: report of a National Institute of Mental Health Conference. Psychopharmacol Bull. 33,3–11 (1997).
- •Reviews outcome criteria for dysthymia.
- Dunner DL, Schmaling KB, Hendrickson H, Becker J, Lehman A, Bea C. Cognitive therapy versus fluoxetine in the treatment of dysthymic disorder. Depression 4,34–41 (1996).
- •Only study thus far reported of CBT in dysthymia.
- McCullough JP Jr. Cognitive—behavioral analysis system of psychotherapy: An interactional treatment for dysthymic disorder. Psychiatry 47,234–250 (1984).
- McCullough JP Jr. Treatment for chronic depression: Cognitive Behavioral Analysis System of Psychotherapy (CBASP). Guilford Press, New York, NY, USA (2000).
- ••Treatment manual for CBASP.
- Markowitz JC. Psychotherapy of dysthymia. A117. I Psychiatry151,1114–1121 (1994).
- Markowitz JC. Psychotherapy for dysthymic disorder. PTchiatr Clin. N Am. 19,133–149 (1996).
- Thase ME, Reynolds CF, Frank E etal Response to cognitive—behavioral therapy in clinical depression. Psychiatry Res. 3, 204–214 (1994).
- Howland RII. Pharmacotherapy of dysthymia: A review. j Clin. PTchophalmacol. 11, 83–92 (1991).
- Dunner DL. Treatment of dysthymic disorder. Depn-ssion Anxiety 8\(Suppl. 1), 54–58 (1998).
- Rosenthal J, Hemlock C, Hellerstein DJ etal A preliminary study of serotonergic antidepressants in treatment of dysthymia. Porg Neumpsychopharmacol Biol. Psychiatry 16,933–941 (1992).
- Hellerstein DJ, Yanowich P, Rosenthal J etal A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia. Aimj Psychiatry 150,1169–1175 (1993).
- •First placebo-controlled study of an SSRI in dysthymia.
- Ravindram AV, Bialik RJ, Lapierre YD. Therapeutic efficacy of specific serotonin re-uptake inhibitors (SSRIs) in dysthymia. Can. PTchiatry 39,21–26 (1994).
- Nobler MS, Devenand DP, Kim MK etal Fluoxetine treatment of dysthymia in the elderly. j Clin. PTchiatry57, 254–256 (1996).
- Vanelle JM, Attar-Levy D, Poirer Bouhassira M, Blin P, Olie JR Controlled efficacy study of fluoxetine in dysthymia. Br. Fiychiatry170,345–350 (1997).
- Dunner DL, Hendrickson HE, Bea C, Budech CB. Venlafaxine in dysthymic disorder. j Gun. Psychiatry 58,528–531 (1997).
- Ravindran AV, Charbonneau Y, Zaharia MD, al-Zaid K, Wiens A, Anisman H. Efficacy and tolerability of venlafaxine in the treatment of primary dysthymia. fiychiatry Neurosci. 23,288–292 (1998).
- Dunner DL, Hendrickson HE, Bea C, Budech CB, Friedman SD. Dysthymic disorder: Treatment with citalopram. Depression Anxiety51, 18–22 (2002).
- Dunner DL. Dysthymic Disorder. Presented at the 151st Annual Meeting, American Psychiatric Association, Toronto, Canada, May 30—June 4, (Abstracts p. 322) (1998).
- Dunner DL, Hendrickson HE, Bea C, Budech CB, O'Connor E. Dysthymic disorder: Treatment with mirtazapine. Depression Anxiety10, 68–72 (1999).
- Hellerstein DS, Batchelder S, Kreditor D et al Bupropion sustained release in dysthymic disorder. Presented at the 152nd Annual Meeting of the American Psychiatric Association, May 15–20, Washington, DC, USA (1999).
- Kocsis JH, Friedman RA, Markowitz JC et al. Maintenance therapy for chronic depression: A controlled trial of desipramine. Azrh. Gen Psychiatry53, 769–774 (1996).
- Keller MB, Gelenberg AJ, Hirschfeld RMA etal The treatment of chronic depression: Part 2. A double-blind, randomized trial of sertraline and imipramine. j Clin. fisychtry59, 598–607 (1998).
- Keller MB, McCullough UP, Klein DN et al. A comparison of nefazodone, the cognitive behavioral analysis system of psychotherapy and their combination for the treatment of chronic depression. N Engl. I Med. 342,1462-1470 (2000). First study to demonstrate better efficacy for psychotherapy and medication than either condition alone for treatment of depression.
- Ravindran AV, Anisman H, Merali Z etal. Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: clinical symptoms and functional impairments. Am j Psychiatry 156,1608–1617 (1999).
- Dunner DL. Acute and maintenance treatment of chronic depression. j Gun. Psychiatry 62 (Suppl. 6), 10–16 (2001).
- Pages IQ, Dunner DL. Focus on dysthymic disorder and chronic depression. In: The Psychiatric Clinics of North America Annual of Drug Therapy 1997 Dunner DL, Rosenbaum JF (Eds). WB Saunders Co., Philadelphia, PA, USA, 91–109 (1997). Affiliation